Arthroscopic Treatment: Bony Lesions

2016 ◽  
pp. 541-553
Author(s):  
Thomas G. Sampson
TRAUMA ◽  
2017 ◽  
Vol 18 (4) ◽  
pp. 48-53
Author(s):  
V.H. Lutsyshyn ◽  
A.V. Kalashnikov ◽  
O.V. Maiko ◽  
V.M. Maiko

2021 ◽  
Vol 24 ◽  
pp. 264-270
Author(s):  
Ioannis Pantekidis ◽  
Michael-Alexander Malahias ◽  
Stefania Kokkineli ◽  
Emmanouil Brilakis ◽  
Emmanouil Antonogiannakis

Hand Clinics ◽  
1999 ◽  
Vol 15 (3) ◽  
pp. 479-488
Author(s):  
John M. Bednar

1995 ◽  
Vol 26 (4) ◽  
pp. 721-729 ◽  
Author(s):  
Bing Siang Gan ◽  
Robert S. Richards ◽  
James H. Roth

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Kuishuai Xu ◽  
Liang Zhang ◽  
Rui Shen ◽  
Cailin Wang ◽  
Tianyu Li ◽  
...  

Abstract Background To explore whether previous arthroscopic knee surgery affects future total knee arthroplasty (TKA) results or not. Methods A total of 56 patients with the previous arthroscopic treatment on one knee underwent subsequent bilateral total knee arthroplasty in our hospital from September 2012 to July 2018. Data on each patient were collected in regards to changes in postoperative clinical and functional scores, various other scores, as well as postoperative functional recovery and complications. We defined the knees with a previous arthroscopic history as group A, and the counter side as group B. The Knee Society clinical score, functional scores, range of motion (ROM), finger joint size (FJS), visual analogue scale (VAS) scores were assessed before and after surgery. Using the Kolmogorov-Smirnov Test to test the normality of continuous variables, and the chi-square test to compare the rate of reoperation and complications between two groups. For all statistical comparisons, P < 0.05 was considered significant. Results There were no statistically significance differences found in postoperative Knee Society clinical scores and functional scores between group A and group B, as well as in ROM, FJS, VAS scores and local complications. Conclusion There were no statistically significant differences found in postoperative functional recovery and complications in patients, who underwent total knee arthroplasty with previous knee arthroscopy.


2021 ◽  
Author(s):  
Arasch Wafaisade ◽  
Bertil Bouillon ◽  
Maurice Balke ◽  
Paola Kappel

2020 ◽  
Vol 22 (Supplement_3) ◽  
pp. iii397-iii397
Author(s):  
Aaron Goldberg ◽  
Chenue Abongwa ◽  
Jody Pathare ◽  
Clay Hoerig ◽  
Michael Muhonen ◽  
...  

Abstract We report two cases of unusual extraneural metastasis in patients with embryonal tumors without central nervous system disease progression and prolonged survival. The first patient presented at 16 years of age with atypical teratoid rhabdoid tumor of the cervical spine. The tumor was confirmed to have loss of INI1, SMARCB1 deletion of exons 1–3, and heterozygous deletion of 22q11.2. The patient received treatment initially per ACNS0333 with high dose chemotherapy and tandem autologous transplants. The patient developed a biopsy-confirmed liver metastasis six months from diagnosis and, subsequently, had disease progression including liver metastases, bony lesions, muscle involvement, and lung nodules. Two and a half years from diagnosis the patient has still not had a relapse in the CNS. The second patient presented with medulloblastoma isolated to the posterior fossa at 11 years of age and was treated on SJMB03 protocol with craniospinal irradiation and high dose chemotherapy. He had his first recurrence in the temporal lobe three years post treatment. He had multiple recurrences in the brain over the next five years treated with re-resections, adjuvant chemotherapy, and gamma knife radiotherapy. He then developed cervical lymphadenopathy, bony lesions, liver lesions, and lung nodules. Cervical lymph node biopsy confirmed medulloblastoma. Next generation sequencing from recurrent tumor showed somatic mutations in p53, KDM6A, and PPP2R1A. Fourteen years from treatment, he has now developed a temporal lobe lesion. These cases are notable for prolonged survival despite widely metastatic disease and genomics predicting poor prognosis as well as metastatic disease disproportionate to CNS disease.


Sign in / Sign up

Export Citation Format

Share Document